
Hope A. Robinson
Examiner (ID: 13788, Phone: (571)272-0957 , Office: P/1652 )
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1653, 1656, 1652 |
| Total Applications | 1913 |
| Issued Applications | 1013 |
| Pending Applications | 293 |
| Abandoned Applications | 631 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17913571
[patent_doc_number] => 20220315966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => METHOD FOR MANUFACTURING FERMENTATION PRODUCTS, AND SENSOR DEVICE USED FOR SAME
[patent_app_type] => utility
[patent_app_number] => 17/807998
[patent_app_country] => US
[patent_app_date] => 2022-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10255
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17807998
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/807998 | METHOD FOR MANUFACTURING FERMENTATION PRODUCTS, AND SENSOR DEVICE USED FOR SAME | Jun 20, 2022 | Abandoned |
Array
(
[id] => 18334973
[patent_doc_number] => 20230126921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => NON-NATURAL MICROBIAL ORGANISMS WITH IMPROVED ENERGETIC EFFICIENCY
[patent_app_type] => utility
[patent_app_number] => 17/843589
[patent_app_country] => US
[patent_app_date] => 2022-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75997
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17843589
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/843589 | NON-NATURAL MICROBIAL ORGANISMS WITH IMPROVED ENERGETIC EFFICIENCY | Jun 16, 2022 | Pending |
Array
(
[id] => 19280010
[patent_doc_number] => 20240216483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => THERAPEUTIC REGIMEN WITH DNASE
[patent_app_type] => utility
[patent_app_number] => 18/562803
[patent_app_country] => US
[patent_app_date] => 2022-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6671
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18562803
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/562803 | THERAPEUTIC REGIMEN WITH DNASE | May 23, 2022 | Pending |
Array
(
[id] => 19332412
[patent_doc_number] => 20240246842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => Immobilized Microbes for Water Treatment
[patent_app_type] => utility
[patent_app_number] => 18/554192
[patent_app_country] => US
[patent_app_date] => 2022-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20757
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18554192
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/554192 | Immobilized Microbes for Water Treatment | Apr 25, 2022 | Pending |
Array
(
[id] => 18879085
[patent_doc_number] => 20240002454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => MOLECULAR PEPTIDE MUTANT
[patent_app_type] => utility
[patent_app_number] => 18/255108
[patent_app_country] => US
[patent_app_date] => 2022-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1770
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18255108
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/255108 | MOLECULAR PEPTIDE MUTANT | Apr 24, 2022 | Pending |
Array
(
[id] => 17790257
[patent_doc_number] => 20220249348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => METHODS FOR TREATING CELLULITE
[patent_app_type] => utility
[patent_app_number] => 17/727118
[patent_app_country] => US
[patent_app_date] => 2022-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17727118
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/727118 | METHODS FOR TREATING CELLULITE | Apr 21, 2022 | Abandoned |
Array
(
[id] => 19263723
[patent_doc_number] => 20240207420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => ENZYMATICALLY-CLEAVABLE GLYCIDYL METHACRYLATE HYALURONIC ACID
[patent_app_type] => utility
[patent_app_number] => 18/555956
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8111
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18555956
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/555956 | ENZYMATICALLY-CLEAVABLE GLYCIDYL METHACRYLATE HYALURONIC ACID | Apr 19, 2022 | Pending |
Array
(
[id] => 20220193
[patent_doc_number] => 20250283124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-11
[patent_title] => POLYHYDROXYALKANOATE-PRODUCING BACTERIA AND METHODS FOR MAKING AND USING THEM
[patent_app_type] => utility
[patent_app_number] => 18/552032
[patent_app_country] => US
[patent_app_date] => 2022-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18552032
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/552032 | POLYHYDROXYALKANOATE-PRODUCING BACTERIA AND METHODS FOR MAKING AND USING THEM | Mar 23, 2022 | Pending |
Array
(
[id] => 19969888
[patent_doc_number] => 12338481
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-24
[patent_title] => Method for producing 2-methyl-butyric acid by bacterial fermentation
[patent_app_type] => utility
[patent_app_number] => 17/703519
[patent_app_country] => US
[patent_app_date] => 2022-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13456
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17703519
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/703519 | Method for producing 2-methyl-butyric acid by bacterial fermentation | Mar 23, 2022 | Issued |
Array
(
[id] => 19004954
[patent_doc_number] => 20240069025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => METHOD FOR SIZE BASED EVALUATION OF PANCREATIC PROTEIN MIXTURE
[patent_app_type] => utility
[patent_app_number] => 18/262318
[patent_app_country] => US
[patent_app_date] => 2022-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6929
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18262318
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/262318 | METHOD FOR SIZE BASED EVALUATION OF PANCREATIC PROTEIN MIXTURE | Mar 22, 2022 | Pending |
Array
(
[id] => 19060398
[patent_doc_number] => 11939608
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => Engineered heme-binding compositions and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/698576
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 26375
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17698576
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/698576 | Engineered heme-binding compositions and uses thereof | Mar 17, 2022 | Issued |
Array
(
[id] => 19940490
[patent_doc_number] => 12312612
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-27
[patent_title] => Acid phosphatase mutants and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 17/694779
[patent_app_country] => US
[patent_app_date] => 2022-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 0
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17694779
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/694779 | Acid phosphatase mutants and methods of using the same | Mar 14, 2022 | Issued |
Array
(
[id] => 19172860
[patent_doc_number] => 20240158834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => COMPOSITIONS AND METHODS FOR BIOLOGICAL SAMPLE PROCESSING
[patent_app_type] => utility
[patent_app_number] => 18/550412
[patent_app_country] => US
[patent_app_date] => 2022-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22346
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18550412
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/550412 | COMPOSITIONS AND METHODS FOR BIOLOGICAL SAMPLE PROCESSING | Mar 13, 2022 | Pending |
Array
(
[id] => 17759231
[patent_doc_number] => 20220232843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => Glycosylated Beta-Galactosidase Compositions Having Improved Transgalactosylating Activity
[patent_app_type] => utility
[patent_app_number] => 17/687786
[patent_app_country] => US
[patent_app_date] => 2022-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17904
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17687786
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/687786 | Method of glycation of a polypeptide | Mar 6, 2022 | Issued |
Array
(
[id] => 19188101
[patent_doc_number] => 20240167014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => Stable storage of enzymes
[patent_app_type] => utility
[patent_app_number] => 18/548909
[patent_app_country] => US
[patent_app_date] => 2022-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14382
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18548909
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/548909 | Stable storage of enzymes | Mar 3, 2022 | Pending |
Array
(
[id] => 19142190
[patent_doc_number] => 20240141014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => MUTANT PD-1 EXTRACELLULAR DOMAINS
[patent_app_type] => utility
[patent_app_number] => 18/279131
[patent_app_country] => US
[patent_app_date] => 2022-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35992
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -186
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18279131
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/279131 | MUTANT PD-1 EXTRACELLULAR DOMAINS | Mar 2, 2022 | Abandoned |
Array
(
[id] => 17982934
[patent_doc_number] => 20220348970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => METHODS AND COMPOSITIONS FOR 3-HYDROXYPROPIONATE PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 17/683101
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20872
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17683101
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/683101 | METHODS AND COMPOSITIONS FOR 3-HYDROXYPROPIONATE PRODUCTION | Feb 27, 2022 | Pending |
Array
(
[id] => 19464168
[patent_doc_number] => 20240317837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => FUSION PROTEINS COMPRISING A PROTEIN WITH PHASE BEHAVIOR
[patent_app_type] => utility
[patent_app_number] => 18/546061
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52945
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -113
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18546061
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/546061 | FUSION PROTEINS COMPRISING A PROTEIN WITH PHASE BEHAVIOR | Feb 17, 2022 | Pending |
Array
(
[id] => 19188094
[patent_doc_number] => 20240167007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => MUTATED ARYLSULFATASE A WITH INCREASED STABILITY
[patent_app_type] => utility
[patent_app_number] => 18/546696
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13584
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18546696
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/546696 | MUTATED ARYLSULFATASE A WITH INCREASED STABILITY | Feb 15, 2022 | Pending |
Array
(
[id] => 19449217
[patent_doc_number] => 20240309347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => Fusion Proteins for CRISPR-based Transcriptional Repression
[patent_app_type] => utility
[patent_app_number] => 18/275442
[patent_app_country] => US
[patent_app_date] => 2022-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21035
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18275442
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/275442 | Fusion Proteins for CRISPR-based Transcriptional Repression | Feb 3, 2022 | Pending |